Modern treatment methods in atopic dermatitis - literature overview

Modern treatment methods in atopic dermatitis - literature overview

Introduction and aim: Atopic dermatitis (AD) is a chronic inflammatory skin disease. It is characterised by periods of exacerbation and remission of symptoms such as pruritus, dry skin and eczematous lesions with characteristic morphology. The aim of this study is to present the current state of kn...

Full description

Saved in:

Bibliographic Details
Main Authors:	Martyna Borowska-Łygan, Jakub Tomaszewski, Wojciech Urban, Konrad Strużek, Jan Biłogras, Kornelia Karamus, Rafał Wojciech Rejmak
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2025-01-01
Series:	Journal of Education, Health and Sport
Subjects:	atopic dermatitis atopic dermatitis treatment JAK - inhibitors biological treatment Dupilumab tralokinumab
Online Access:	https://apcz.umk.pl/JEHS/article/view/56830
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness and Safety of Dupilumab and Tralokinumab for Treating Atopic Dermatitis and Pruritic Skin Disorders in Oncological Patients: A Narrative Review
by: Lauletta G, et al.
Published: (2025-01-01)

Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study
by: Hyun Ji Lee, et al.
Published: (2025-02-01)

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
by: Tiago Torres, et al.
Published: (2024-04-01)

Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD)
by: Marjolein de Bruin-Weller, et al.
Published: (2022-07-01)

Mistakes in the diagnosis and treatment of atopic dermatitis
by: Monika Marko, et al.
Published: (2024-02-01)

Determining atopic dermatitis adult patients’ preferences regarding novel systemic treatment
by: Monika Suszynska, et al.
Published: (2025-01-01)

Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study
by: Filip Rob, et al.
Published: (2025-12-01)

A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries
by: Amani Alfalasi, et al.
Published: (2025-12-01)

Correlation of serum Vitamin D levels and disease severity in patients with atopic dermatitis: A hospital-based, cross-sectional study from North India
by: Shreya Malhan, et al.
Published: (2024-12-01)

The Association of Inflammatory Indexes Derived from Peripheral Blood Cell Count and Clinical Signs with Response to Treatment with Dupilumab in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis
by: Zhang L, et al.
Published: (2025-01-01)

Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
by: Mengmeng Li, et al.
Published: (2025-02-01)

Exploring Social Health in Patients with Atopic Dermatitis: An Observational, Cross-sectional, Questionnaire Based Study on Social Participation and Emotional Support
by: Esmé Kamphuis, et al.
Published: (2025-01-01)

Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre Study
by: Stamatios Gregoriou, et al.
Published: (2025-01-01)

Multimorbidity in adult patients diagnosed with atopic dermatitis
by: Szymon Mućka, et al.
Published: (2025-01-01)

Efficacy of dupilumab with concomitant topical calcineurin inhibitors treatment for preschool children with atopic dermatitis: a retrospective cohort study
by: Wu Liming, et al.
Published: (2025-12-01)

Unmet needs in atopic dermatitis management: an expert consensus
by: Annalisa Patrizi, et al.
Published: (2022-07-01)

Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years
by: Andreas Wollenberg, et al.
Published: (2024-12-01)

Tumors in the setting of dupilumab use: A review of the literature
by: Shumeng Guo, et al.
Published: (2025-01-01)

Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumab
by: Eri Uchiyama, et al.
Published: (2025-01-01)

Associations of Atopic Dermatitis in Late Adolescence with Occupation, Mental Health, Income from Work and Marital Status: A National Longitudinal Study
by: Grigorios Theodosiou, et al.
Published: (2025-01-01)

Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index
by: Gabriele Di Lorenzo, et al.
Published: (2003-01-01)

Atopic dermatitis - the review
by: Joanna Wrona, et al.
Published: (2025-01-01)

Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life
by: Andrew Blauvelt, et al.
Published: (2022-07-01)

Allergen immunotherapy in atopic dermatitis
by: Agnieszka Bogacz-Piaseczyńska, et al.
Published: (2024-08-01)

Asthma and Atopic Diseases in Children with Autism Spectrum Disorders
by: Khaled Saad, et al.
Published: (2024-12-01)

The Association between Atopic Dermatitis Severity and Mood Disturbance among Adults: A Cross-sectional Study
by: Farah F. Albakr, et al.
Published: (2024-12-01)

Comparative study of mouse models of atopic dermatitis
by: Siqi Ye, et al.
Published: (2025-01-01)

The role of exogenous histamine in atopic dermatitis flare-ups
by: Zofia Kowalska, et al.
Published: (2024-08-01)

WhatsApp and atopic dermatitis: a clinical trial
by: Thaís Braga Cerqueira, et al.
Published: (2025-01-01)

Case Report: Severe ophiasis-pattern alopecia areata with concomitant atopic dermatitis in a 5-year-old boy successfully treated with dupilumab
by: Zhendong Wei, et al.
Published: (2025-02-01)

A Cross-sectional Study to Assess the Association of Minor Criteria of Hannifin and Rajka with Age and Gender in Pediatric Atopic Dermatitis Population
by: Garima Bansal, et al.
Published: (2024-12-01)

Thymus and activation-regulated chemokine (CCL17) as a clinical biomarker in atopic dermatitis: significance and limitations in the new treatment era
by: Yoko Kataoka
Published: (2025-01-01)

Atopic dermatitis in childhood and pubertal development: A nationwide cohort studyCapsule Summary
by: Camilla Lomholt Kjersgaard, MD, et al.
Published: (2025-04-01)

Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications
by: Ahmad Vafaeian, et al.
Published: (2025-02-01)

The economic burden of atopic dermatitis in Romania: a broad perspective
by: Alin Codruț Nicolescu, et al.
Published: (2025-01-01)

Dupilumab-induced serum sickness-like reaction in a pediatric patient
by: S. Minhaj Rahman, BA, et al.
Published: (2025-02-01)

Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database
by: Liu J, et al.
Published: (2025-02-01)

A Study on the Classification of Atopic Dermatitis by Spectral Features of Hyperspectral Imaging
by: Eun Bin Kim, et al.
Published: (2025-01-01)

Atopic Dermatitis And Intercourse Difficulties : A Cross-sectional Study of the Northern Finland Birth Cohort 1966 Study
by: Atte Sopenlehto, et al.
Published: (2025-01-01)

Skin microbiota: pathogenic roles and implications in atopic dermatitis
by: Cong Huang, et al.
Published: (2025-01-01)